๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Magnitude of risk for cancer in patients with colorectal adenomas

โœ Scribed by B. C. Morson; H. J. R. Bussey


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
240 KB
Volume
72
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Survival of patients with hereditary col
โœ Lucio Bertario; Antonio Russo; Paolo Sala; Marco Eboli; Paolo Radice; Silvano Pr ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 80 KB ๐Ÿ‘ 2 views

Conflicting data exist on the prognosis of hereditary colorectal cancer. HNPCC patients, in particular, are often reported to have a better survival. We examined 2,340 colorectal-cancer patients treated in our Institution: 144 HNPCC patients (Amsterdam Criteria), 161 FAP patients and 2,035 patients

Predicting the risk of metachronous colo
โœ Meijer, Gerrit A.; Baak, Jan P. A.; Talbot, Ian C.; Atkin, Wendy S.; Meuwissen, ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 499 KB ๐Ÿ‘ 2 views

The prognostic value of quantitative pathological features in rectosigmoid adenomas was investigated, in search of more precise identifiers of adenoma-bearing patients at high risk of metachronous colorectal cancer. In a 'nested case-control study' design, 21 cases with metachronous colon cancer dur

Prognostic index for the development of
โœ Professor I. Taylor; M. A. Mullee; M. J. Campbell ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 280 KB ๐Ÿ‘ 2 views

## Abstract The incidence of synchronous and metachronous liver metastases in patients with colorectal cancer is extremely high. Approximately 25 per cent of patients will have overt liver metastases at the time of presentation, and in the remainder up to 40 per cent will eventually develop liver m

Molecular genotyping for N-acetylation p
โœ Kenji Shibuta; Tadasu Nakashima; Masako Abe; Masami Mashimo; Masaki Mori; Hiroak ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 394 KB ๐Ÿ‘ 1 views

## Background: N-acetylation polymorphism has been documented as a representative pharmacogenetic trait, and also has been implicated ecogenetically in an individual's susceptibility to cancer. however, there still remains controversy concerning the association between colorectal cancer and n-acety